Class II · Moderate risk
Doxazosin Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
FDA drug recalls in 2023
Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,122 recalls, newest first.
Class II · Moderate risk
Doxazosin Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Clopidogrel Tablets USP
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Atorvastatin Calcium Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Atorvastatin Calcium Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Alprazolam C-IV
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Class II · Moderate risk
Alprazolam C-IV
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Class II · Moderate risk
Alprazolam C-IV
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Class II · Moderate risk
Simvastatin 40 mg tablets
cGMP Deviations
Class II · Moderate risk
Rosuvastatin 40mg tablets
cGMP Deviations
Class II · Moderate risk
Rosuvastatin 10mg tablets
cGMP Deviations
Class II · Moderate risk
Rosuvastatin 5mg tablets
cGMP Deviations
Class II · Moderate risk
Ropinirole 2mg tablets
cGMP Deviations
Class II · Moderate risk
Atorvastatin 20 mg tablets
cGMP Deviations
Class II · Moderate risk
Tadalafil 5 mg tablets
cGMP Deviations
Class II · Moderate risk
Simvastatin 10 mg tablets
cGMP Deviations
Class II · Moderate risk
Rosuvastatin 5mg tablets
cGMP Deviations
Class II · Moderate risk
Ropinirole 0.5 mg tablets
cGMP Deviations
Class II · Moderate risk
Glimepiride 2 mg tablets
cGMP Deviations
Class II · Moderate risk
Doxazosin 2 mg tablets
cGMP Deviations
Class II · Moderate risk
Atorvastatin 10 mg tablets
cGMP Deviations
Class II · Moderate risk
Aripiprazole 5mg tablets
cGMP Deviations
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.